JP2008518952A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518952A5
JP2008518952A5 JP2007539281A JP2007539281A JP2008518952A5 JP 2008518952 A5 JP2008518952 A5 JP 2008518952A5 JP 2007539281 A JP2007539281 A JP 2007539281A JP 2007539281 A JP2007539281 A JP 2007539281A JP 2008518952 A5 JP2008518952 A5 JP 2008518952A5
Authority
JP
Japan
Prior art keywords
quencher
base
composition
inactivating compound
pathogen inactivating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007539281A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518952A (ja
JP5346468B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/039392 external-priority patent/WO2006050328A1/en
Publication of JP2008518952A publication Critical patent/JP2008518952A/ja
Publication of JP2008518952A5 publication Critical patent/JP2008518952A5/ja
Application granted granted Critical
Publication of JP5346468B2 publication Critical patent/JP5346468B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007539281A 2004-10-29 2005-10-31 赤血球不活性化プロセスのための改善されたクエンチング方法 Expired - Lifetime JP5346468B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62317704P 2004-10-29 2004-10-29
US60/623,177 2004-10-29
PCT/US2005/039392 WO2006050328A1 (en) 2004-10-29 2005-10-31 Improved quenching methods for red blood cell inactivation process

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012050837A Division JP5718840B2 (ja) 2004-10-29 2012-03-07 赤血球不活性化プロセスのための改善されたクエンチング方法

Publications (3)

Publication Number Publication Date
JP2008518952A JP2008518952A (ja) 2008-06-05
JP2008518952A5 true JP2008518952A5 (cg-RX-API-DMAC7.html) 2008-12-25
JP5346468B2 JP5346468B2 (ja) 2013-11-20

Family

ID=35789172

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007539281A Expired - Lifetime JP5346468B2 (ja) 2004-10-29 2005-10-31 赤血球不活性化プロセスのための改善されたクエンチング方法
JP2012050837A Expired - Lifetime JP5718840B2 (ja) 2004-10-29 2012-03-07 赤血球不活性化プロセスのための改善されたクエンチング方法
JP2013200906A Withdrawn JP2013256537A (ja) 2004-10-29 2013-09-27 赤血球不活性化プロセスのための改善されたクエンチング方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012050837A Expired - Lifetime JP5718840B2 (ja) 2004-10-29 2012-03-07 赤血球不活性化プロセスのための改善されたクエンチング方法
JP2013200906A Withdrawn JP2013256537A (ja) 2004-10-29 2013-09-27 赤血球不活性化プロセスのための改善されたクエンチング方法

Country Status (12)

Country Link
US (1) US7655392B2 (cg-RX-API-DMAC7.html)
EP (1) EP1838355B1 (cg-RX-API-DMAC7.html)
JP (3) JP5346468B2 (cg-RX-API-DMAC7.html)
CN (2) CN101094692A (cg-RX-API-DMAC7.html)
AU (2) AU2005302256B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518198B8 (cg-RX-API-DMAC7.html)
CA (1) CA2585621C (cg-RX-API-DMAC7.html)
DK (1) DK1838355T3 (cg-RX-API-DMAC7.html)
ES (1) ES2429088T3 (cg-RX-API-DMAC7.html)
PL (1) PL1838355T3 (cg-RX-API-DMAC7.html)
PT (1) PT1838355E (cg-RX-API-DMAC7.html)
WO (1) WO2006050328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69826521T2 (de) * 1998-01-06 2005-09-29 Cerus Corp., Concord Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
JP5346468B2 (ja) 2004-10-29 2013-11-20 シーラス コーポレイション 赤血球不活性化プロセスのための改善されたクエンチング方法
KR101896430B1 (ko) * 2008-04-09 2018-09-10 세루스 코포레이션 적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
US20160081328A1 (en) * 2013-05-10 2016-03-24 President And Fellows Of Harvard College Solutions for Red Blood Cells
EA201790265A1 (ru) 2014-07-23 2017-07-31 Сирус Корпорейшн Способы получения тромбоцит-содержащих продуктов
KR20250033333A (ko) 2015-03-10 2025-03-07 헤마넥스트 인코포레이티드 산소 감소 1회용 키트, 장치 및 이의 사용 방법
BR122022005103B1 (pt) 2015-04-23 2023-03-14 Hemanext Inc Dispositivo de armazenamento de sangue para armazenar sangue depletado de oxigênio e método para armazenar sangue depletado de oxigênio
PT3297641T (pt) 2015-05-18 2025-10-09 Hemanext Inc Métodos de armazenamento de sangue total e respetivas composições
CN122182613A (zh) 2015-06-26 2026-06-12 塞鲁斯公司 冷沉淀物组合物及其制备方法
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
CN109195632A (zh) * 2016-05-27 2019-01-11 新健康科学股份有限公司 厌氧血液储存和病原体失活方法
AU2017382449B2 (en) * 2016-12-23 2024-10-24 Cerus Corporation Systems and methods for testing and screening using compound bound substrates
US20190321407A1 (en) * 2016-12-31 2019-10-24 Cerus Corporation Compositions and methods for preparation of red blood cells
EP4606379A3 (en) 2017-03-03 2025-11-19 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
AU2018338097B2 (en) 2017-09-20 2023-07-13 Cerus Corporation Compositions and methods for pathogen inactivation of platelets
JP7311518B2 (ja) 2017-12-29 2023-07-19 シーラス コーポレイション 生物学的流体を処理するためのシステムおよび方法
US20210227827A1 (en) * 2018-07-27 2021-07-29 Zata Pharmaceuticals, Inc. Method for pathogens, microorganisms, and parasites inactivation
CA3113655A1 (en) * 2018-09-20 2020-03-26 Cerus Corporation Methods and kits for preparing pathogen-inactivated whole blood
WO2020263745A1 (en) 2019-06-22 2020-12-30 Cerus Corporation Systems and methods for implementing treatment of biological fluids
CN114173842B (zh) 2019-06-22 2026-07-14 塞鲁斯公司 生物流体处理系统
JP7645203B2 (ja) 2019-06-28 2025-03-13 シーラス コーポレイション 生物学的流体処理デバイスを実装するためのシステム及び方法
EP4240757A2 (en) 2020-11-09 2023-09-13 Takeda Pharmaceutical Company Limited Purification of fviii from plasma using silicon oxide adsorption

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2402665A (en) 1942-11-12 1946-06-25 Du Pont Chemical process
IT1093275B (it) 1978-01-26 1985-07-19 Snam Progetti Composizione adatta alla purificazione del sangue e suoi impieghi
US4337269A (en) 1979-07-23 1982-06-29 Sutton Laboratories, Inc. Preservative compositions
US4748120A (en) 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5281579A (en) 1984-03-23 1994-01-25 Baxter International Inc. Purified virus-free hemoglobin solutions and method for making same
US4971760A (en) 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US4944920A (en) 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
US4920143A (en) 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5055485A (en) 1988-12-02 1991-10-08 New York Blood Center, Inc. Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5753258A (en) 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
GB9218581D0 (en) 1992-09-02 1992-10-14 Pall Corp Removal of unwanted fluids from processed blood products
CA2165065A1 (en) 1993-06-23 1995-01-05 Henrietta Margolis-Nunno System for viral inactivation of blood
US5591350A (en) 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
SE9402472L (sv) 1994-07-13 1996-01-14 Forskarpatent I Linkoeping Ab Modifierade ytor
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5660731A (en) 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US5637451A (en) 1995-03-29 1997-06-10 New York Blood Center, Inc. Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
EP0840781B1 (en) 1995-06-07 2009-12-09 Cerus Corporation Methods and devices for the removal of psoralens from blood products
US6544727B1 (en) 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
AU703108B2 (en) 1995-06-07 1999-03-18 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US20020192632A1 (en) 1995-06-07 2002-12-19 Hei Derek J. Method and devices for the removal of psoralens from blood products
EP0773716A4 (en) 1995-06-07 1999-08-04 Cerus Corp TREATMENT OF RED BLOOD CELL SOLUTIONS WITH ANTIVRAL ACTIVE SUBSTANCES
AU7717396A (en) 1995-06-29 1997-02-05 Hemasure, Inc. Inactivation of pathogens using hydroxymethylamines
US6136586A (en) 1995-08-29 2000-10-24 Vi Technologies, Inc. Methods for the selective modification of viral nucleic acids
US6114108A (en) 1995-08-29 2000-09-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of viral nucleic acids
CA2236873A1 (en) 1995-11-06 1997-05-15 New York Blood Center, Inc. Viral inactivation treatment of red blood cells using phthalocyanines and red light
WO1997018844A1 (en) 1995-11-21 1997-05-29 Pall Corporation Inactivation method and system in biological fluids
US6514987B1 (en) 1997-01-06 2003-02-04 Cerus Corporation Frangible compounds for pathogen inactivation
ATE243198T1 (de) 1997-01-06 2003-07-15 Cerus Corp Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen
US6093725A (en) 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
US6093564A (en) 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
DE69826521T2 (de) * 1998-01-06 2005-09-29 Cerus Corp., Concord Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
US6277337B1 (en) * 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6150109A (en) 1999-01-25 2000-11-21 V. I. TECHNOLOGIES, Inc. Lipophilic quenching of viral inactivating agents
CN1436083A (zh) * 2000-05-31 2003-08-13 塞鲁斯公司 制备病原体灭活的低免疫原性红细胞溶液
CN100417325C (zh) * 2000-11-04 2008-09-10 王祥文 卫生灭菌消毒剂
US20030113704A1 (en) * 2000-12-21 2003-06-19 Cerus Corporation Methods for inactivation of pathogens in biological materials
CN1186099C (zh) * 2001-12-13 2005-01-26 孙岩军 麻醉机呼吸回路清洗消毒的方法及其操作步骤
JP5346468B2 (ja) 2004-10-29 2013-11-20 シーラス コーポレイション 赤血球不活性化プロセスのための改善されたクエンチング方法

Similar Documents

Publication Publication Date Title
Sainz et al. Leghemoglobin is nitrated in functional legume nodules in a tyrosine residue within the heme cavity by a nitrite/peroxide‐dependent mechanism
CN1171852C (zh) 灭活生物组合物中的病毒的方法
JP2011516570A5 (cg-RX-API-DMAC7.html)
TW200716667A (en) Binding agents
MY174493A (en) Binding agents
WO2004094647A3 (en) Methods of treating diseases responsive to induction of apoptosis and screening assays
BRPI0514340A (pt) formulações de estabilização
CN1214246C (zh) 血红蛋白的测定方法和血红蛋白糖化率的测定方法
NO20071432L (no) Fremgangsmate for konsentrasjon av antistoffer of terapeutiske produkter derav.
EA201270214A1 (ru) Способы очистки рекомбинантного adamts13 и других белков и их композиции
NO20075697L (no) Humane monoklonale antistoffer mot programmert dod 1 (PD-1) og fremgangsmater for a behandle cancer ved anvendelse av anti-PD-1 antistoffer alene eller i kombinasjon med andre immunterapeutika
BRPI0518198B8 (pt) método ex vivo para tratar uma composição de células hemácias para inativar um patógeno, se presente, bem como composição e kit
Edwards et al. Blood and liver glutathione during protein deprivation.
WO2005042060A3 (en) Method and composition comprising pyruvate, inosine, adenine, phosphate and an aziridino compound for treating a biological sample
NO20063969L (no) Redusjon av akrylamid i ferdigmat
JP2021061802A (ja) Ｌ−グルタミンの測定方法、及びそのためのキット
EP2175020A1 (en) Reduction of RNase activity in complex fluidic samples
JP2005110507A (ja) 試薬の安定化方法
WO2004094648A3 (en) Methods of treating diseases responsive to induction of apoptosis and screening assays
TW200637830A (en) Erastin and erastin binding proteins, and uses thereof
Gafni Age-related effects in coenzyme binding patterns of rat muscle glyceraldehyde-3-phosphate dehydrogenase
Meyer et al. Thioredoxin alkylation by a dihaloethane-glutathione conjugate
DE602004016006D1 (de) Screening-verfahren
WO2004008942A3 (en) Rapid process for purification and concentration of plasmin
Nagaraj et al. Modulation of advanced glycation endproduct synthesis by kynurenines in human lens proteins